Viveve Medical Inc reports results for the quarter ended in September - Earnings Summary

Viveve Medical

10/11/2022 22:02

* Viveve Medical Inc  VIVE.OQ  reported a quarterly adjusted
loss
of 59 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 66 cents per share.
    * Revenue rose 4.2% to $1.68 million from a year ago;
analysts
expected $1.71 million. 
    * Viveve Medical Inc's reported EPS for the quarter was a
loss
of 59 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Viveve Medical Inc shares had fallen by 23.5% this
quarter and
lost 54.4% so far this year.
    * The company reported a quarterly loss of $6.32 million.
    * Wall Street's median 12-month price target for Viveve
Medical
Inc is $4.68 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.66          -0.59          Beat
 Jun. 30 2022      -0.67          -0.67          Met
 Mar. 31 2022      -0.67          -0.67          Met
 Dec. 31 2021      -0.59          -0.72          Missed